
Although prostate cancer is the second leading cause of cancer-related death in men, most patients do not experience aggressive disease. To help determine who needs treatment and who can be safely monitored, active surveillance (AS) with MRI has emerged as a strategy for managing low-risk disease.
In a recent article in @RadioGraphics, authors led by Arthur Ogata, MD, University of São Paulo, and Giorgio Brembilla, MD, Università Vita-Salute San Raffaele, Italy, discuss the foundations, key updates and practical applications of PRECISE version 2. They also review prostate anatomy, histologic classification and disease staging.
Read the full article: bit.ly/48Rd7wU
#ProstateCancer #MRI

English



















